Clinical Trials Browser

Phase 4 × Bevacizumab × 90 days × Clear all

NCT04813913 2026-02-06

VASCATAQ

Phase 4 Completed

Neoplasms

NCT07358520 2026-01-22

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Phase 4 Not yet recruiting

Proteinuria

NCT07094893 2026-01-14

ARIEL-ENGIC

Phase 4 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms